Projects funded by the NCN
The role of 5-hydroxymethyluracil in chronic lymphocytic leukemia development
2020/39/O/NZ5/00852
Keywords:
5-hydroxymethyluracil SMUG1 chronic lymphocytic leukemia epigenetics
Descriptors:
- NZ5_1: Etiology of human diseases
- NZ5_3: Pathogenesis of human diseases
- NZ2_2: Genomics, transcriptomics, epigenomics
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny
woj. kujawsko-pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 2 - announced on 2020-09-15
Amount awarded: 541 680 PLN
Project start date (Y-m-d): 2021-07-12
Project end date (Y-m-d): 2025-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.